Bafna Pharmaceuticals Shareholding Pattern & Promoter Holding

Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026

As of Sep 2026, promoters hold 75.00% of Bafna Pharmaceuticals, FIIs hold 9.34%, DIIs hold — and the public holds 15.66%. Promoter holding was unchanged from Jun 2026.

Get an alert when Bafna Pharmaceuticals reports results or its shareholding changes. Free account.

Promoters

75.00%

unchanged QoQ

FIIs

9.34%

unchanged QoQ

DIIs

—

— QoQ

Public

15.66%

unchanged QoQ

Bafna Pharmaceuticals shareholding, quarter by quarter

QuarterPromotersFIIsPublicShareholders
Sep 202675.00%9.34%15.66%6,810
Jun 202675.00%9.34%15.66%7,062
Mar 202675.00%9.34%15.66%6,928
Dec 202575.00%9.34%15.66%7,119
Sep 202575.00%9.34%15.66%7,572
Jun 202575.00%9.34%15.66%7,283
Mar 202575.00%8.53%16.47%7,142
Dec 202488.29%0.00%11.70%7,214
Sep 202488.29%0.00%11.70%7,295
Jun 202488.29%0.00%11.71%7,391
Mar 202488.29%0.00%11.70%7,539
Dec 202388.42%0.00%11.57%7,367

Promoters · FIIs (foreign institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.

Value of the promoter stake

At a market capitalisation of ₹1.13k cr, the promoter group's 75.00% stake is worth ₹847 cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.

Promoter holding in Pharmaceuticals & Biotechnology peers

Bafna Pharmaceuticals shareholding: common questions

What is the promoter holding in Bafna Pharmaceuticals?

Promoters hold 75.00% of Bafna Pharmaceuticals as of Sep 2026. Their stake was unchanged from Jun 2026.

How much do FIIs hold in Bafna Pharmaceuticals?

Foreign institutional investors (FIIs) held 9.34% of Bafna Pharmaceuticals in Sep 2026, unchanged versus Jun 2026.

Is the promoter holding in Bafna Pharmaceuticals pledged?

The latest disclosed shareholding pattern shows no pledged promoter shares in Bafna Pharmaceuticals.

How has Bafna Pharmaceuticals's promoter holding changed in the last year?

Promoter holding moved from 75.00% in Sep 2025 to 75.00% in Sep 2026 (unchanged).

How many shareholders does Bafna Pharmaceuticals have?

Bafna Pharmaceuticals had 6,810 shareholders in Sep 2026, compared with 7,062 in Jun 2026.